These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16380465)

  • 1. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
    Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
    Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
    Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
    Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
    FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
    Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
    Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
    Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
    J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
    Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
    J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
    Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
    J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats.
    Liu BC; Huang HQ; Luo DD; Ma KL; Liu DG; Liu H
    Chin Med J (Engl); 2006 Jun; 119(12):1010-6. PubMed ID: 16805985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
    Riser BL; Cortes P
    Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
    Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
    Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
    Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
    Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y; Wang B; Keum JS; Jaffa AA
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
    Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
    Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
    Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
    J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
    Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G
    Diabetes; 2010 Apr; 59(4):1046-54. PubMed ID: 20068137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.